COMPANY
ACF Equity Research

ACF Equity Research
Accuracy | Clarity | Foresight

53
Insights
22.6k
Views
3
Followers
Equities
Refresh
12 Nov 2024 22:00Issuer-paid

BrainStorm Cell Therapeutics (BCLI) Update 11112024

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) develops NurOwn® stem cell therapy for NDDs – BCLI’s first target is ALS (MND/Lou...

Logo
125 Views
Share
bullishCIEL
08 Nov 2024 09:27Issuer-paid

Ciel Limited (CIEL) - Conglomerate Strategy Fixes Textile Challenge

CIEL Limited (SEMDEX: CIEL) is a Mauritius listed diversified industrial company with a very attractive long run growth opportunity.

Logo
107 Views
Share
02 Nov 2024 09:50Issuer-paid

AsiaFIN Holdings Corp (ASFH) Pre-Results 3Q24 30102024

AsiaFIN Holdings Corp. (OTCQB : ASFH) - aggressive growth inflection point. ASFH provides IP protected fintech solutions to ASEAN based financial...

Logo
352 Views
Share
04 Oct 2024 00:00Issuer-paid

BrainStorm Cell Therapeutics (BCLI) Update Note 03102024

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) develops NurOwn® stem cell therapy for NDDs – BCLI’s first target is ALS (MND/Lou Gehrig’s). We...

Logo
267 Views
Share
01 Oct 2024 00:00Issuer-paid

BrainStorm Cell Therapeutics (BCLI) Flash Note 30092024

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) develops NurOwn® stem cell therapy for NDDs – BCLI’s first target is ALS (MND/Lou Gehrig’s). BCLI...

Logo
208 Views
Share
x